Kiora Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.977; its P/E ratio is -0.19; Kiora Pharmaceuticals is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	$ 100.00K	-	-
EBIT	$ -3.32M	$ -2.37M	$ -1.87M	-	$ -3.37M
EBITDA	$ -3.31M	-	$ -1.86M	-	$ -3.36M
Net Income Common Stockholders	$ -3.27M	$ -2.61M	$ -1.87M	-	$ -5.12M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 5.40M	$ 7.95M	$ 3.43M	$ 6.00M	$ 4.80M
Total Assets	$ 15.90M	$ 19.88M	$ 16.48M	$ 18.71M	$ 17.66M
Total Debt	$ 18.73K	$ 39.01K	$ 73.29K	$ 105.78K	$ 136.25K
Net Debt	$ -5.38M	$ -7.91M	$ -3.35M	$ -5.89M	$ -4.67M
Total Liabilities	$ 7.79M	$ 6.24M	$ 6.37M	$ 7.27M	$ 7.14M
Stockholders Equity	$ 8.10M	$ 13.69M	$ 10.19M	$ 11.37M	$ 10.52M
Cash Flow	-
Free Cash Flow	$ -2.52M	-	$ -3.07M	-	$ -2.97M
Operating Cash Flow	$ -2.52M	-	$ -3.07M	-	$ -2.97M
Investing Cash Flow	-	-	-	-	$ 0.00
Financing Cash Flow	-	-	$ 513.17K	-	$ 5.38M

Currency in USD

Kiora Pharmaceuticals Earnings and Revenue History

Income Statement >

Kiora Pharmaceuticals Debt to Assets

Balance Sheet >

Kiora Pharmaceuticals Cash Flow

Cash Flow >

Kiora Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing